G. Chaby

New‐onset vitiligo and progression of pre‐existing vitiligo during treatment with biological agents in chronic inflammatory diseases

L. Méry‐Bossard, K. Bagny, G. Chaby et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 83 citations

Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population

Marthe Plaquevent, F. Tétart, L. Fardet et al. · Journal of Investigative Dermatology · 2018 · 83 citations · Full text

French General Population, Higher Frequency, Bullous Pemphigoid Patients +2

Prognostic factors associated with healing of venous leg ulcers: a multicentre, prospective, cohort study

G. Chaby, Patricia Senet, O. Ganry et al. · British Journal of Dermatology · 2013 · 70 citations

Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy

C. Mignard, Maud Maho‐Vaillant, Marie-Laure Golinski et al. · JAMA Dermatology · 2020 · 68 citations · Full text

Incidence of and mortality from epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) in France during 2003–16: a four‐source capture–recapture estimate

G. Chaby, Carla Maldini, Cynthia Haddad et al. · British Journal of Dermatology · 2019 · 59 citations